ITEOS THERAPEUTICS, INC.

Profile

Company Names

ITEOS THERAPEUTICS, INC.

Addresses

139 MAIN STREET, CAMBRIDGE, MA 02142

Phone Numbers

857-204-4583

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$125,358,806.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-03-24 
$125,358,806.00 
$125,358,806.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PRIYANKA 
 
BELAWAT 
DIRECTOR
NEURELIS, INC.   |  ITEOS THERAPEUTICS, INC.
DETLEV 
 
BINISZKIEWICZ 
DIRECTOR
REKINDLE THERAPEUTICS INC.   |  ITEOS THERAPEUTICS, INC.   |  NEXTPOINT THERAPEUTICS, INC.   |  DEKA BIOSCIENCES, INC.
CHRIS 
 
BUYSE 
DIRECTOR
ITEOS THERAPEUTICS, INC.   |  IMMUNOPRECISE ANTIBODIES LTD.
MICHEL 
 
DETHEUX 
EXECUTIVE OFFICER, DIRECTOR
ITEOS THERAPEUTICS, INC.
ANSBERT 
 
GADICKE 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  CERIMON PHARMACEUTICALS, INC.   |  MPM BIOVENTURES V, L.P.   |  VERASTEM, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  MITOKYNE, INC.   |  CLINICAL INK, INC.   |  VIRACYTE, INC.   |  ALLOVIR, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  ITEOS THERAPEUTICS, INC.   |  ONCOLOGY IMPACT FUND 2, L.P.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  NEXTPOINT THERAPEUTICS, INC.   |  MPM BIOVENTURES 2022, L.P.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
DAVID 
 
HALLAL 
DIRECTOR
SCHOLAR ROCK HOLDING CORP   |  VIRACYTE, INC.   |  ALLOVIR, INC.   |  ITEOS THERAPEUTICS, INC.
JONATHAN 
 
SKIPPER 
DIRECTOR
ITEOS THERAPEUTICS, INC.
TIM 
 
VAN HAUWERMEIREN 
DIRECTOR
ITEOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-04-09
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#